These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3543948)

  • 21. Preclinical selection of new anthracyclines.
    Casazza AM
    Cancer Treat Rep; 1986 Jan; 70(1):43-9. PubMed ID: 3510737
    [No Abstract]   [Full Text] [Related]  

  • 22. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
    Pasman PC; Schouten HC
    Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of correlation between effects of anthracyclines on in vitro cardiac guanyl cyclase and in vivo cardiotoxicity.
    Zbinden G
    Cancer Treat Rep; 1982 Aug; 66(8):1677-8. PubMed ID: 6125261
    [No Abstract]   [Full Text] [Related]  

  • 26. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of cell pharmacokinetics in the modulation of modalities in the administration of anthracyclines].
    Tapiéro H; Boule D; Trincal G; Fourcade A
    Pathol Biol (Paris); 1987 Jan; 35(1):20-6. PubMed ID: 3550608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New aspects of clinical drug resistance: the role of gene amplification and the reversal of resistance in drug refractory cancer.
    Ozols RF; Cowan K
    Important Adv Oncol; 1986; ():129-57. PubMed ID: 3330530
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumour cell resistance to anthracyclines--a review.
    Kaye S; Merry S
    Cancer Chemother Pharmacol; 1985; 14(2):96-103. PubMed ID: 2982511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The in vitro effects and cross-resistance patterns of some novel anthracyclines.
    Twentyman PR; Fox NE; Wright KA; Workman P; Broadhurst MJ; Martin JA; Bleehen NM
    Br J Cancer; 1986 May; 53(5):585-94. PubMed ID: 3459509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.
    Serafino A; Sinibaldi-Vallebona P; Gaudiano G; Koch TH; Rasi G; Garaci E; Ravagnan G
    Anticancer Res; 1998; 18(2A):1159-66. PubMed ID: 9615782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antitumor drug resistance and therapeutic approaches to reverse resistance].
    Tsuruo T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1715-25. PubMed ID: 3899014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of uridine transport through sarcoma-180 cell membrane by anthracycline antibiotics.
    Choudhury SR; Deb JK; Choudhury K; Neogy RK
    Biochem Pharmacol; 1982 May; 31(9):1811-4. PubMed ID: 6954953
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic approach against drug-resistant tumors and their biochemical nature].
    Tsuruo T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1636-41. PubMed ID: 3592707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake kinetics and intracellular distribution of anthracyclines studied by laser cytofluorometry.
    Prosperi E; Croce AC; Bottiroli G; Dasdia T; Supino R
    Basic Appl Histochem; 1983; 27(2):117-27. PubMed ID: 6577857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1988; 10():33-9. PubMed ID: 3079388
    [No Abstract]   [Full Text] [Related]  

  • 37. Anthracyclines.
    Batist G
    Cancer Chemother Biol Response Modif; 2001; 19():47-58. PubMed ID: 11686029
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytofluorescence localization of anthracycline antibiotics.
    Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
    Cancer Res; 1980 Dec; 40(12):4669-76. PubMed ID: 6934029
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical modification of steffimycin B.
    Wiley PF; Elrod DW; Harper DE
    J Antibiot (Tokyo); 1988 Mar; 41(3):343-51. PubMed ID: 3366692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reversal of antitumor drug resistance by modification of membrane transport].
    Tsuruo T
    Seikagaku; 1983 Oct; 55(10):1198-203. PubMed ID: 6400391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.